Checkpoint Therapeutics' Shares Rise After Securing First FDA Approval

WSJDec 14 08:09

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT (Cosibelimab-ipdl)

GlobeNewswireDec 14 07:15

Express News | FDA: Approval of Cosibelimab-Ipdl (Unloxcyt) Granted to Checkpoint Therapeutics

BreakingsDec 14 07:04

Express News | FDA Approves Cosibelimab-Ipdl for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma - Website

BreakingsDec 14 07:03

Trading Halt: Halted at 5:26:59 P.m. ET - Trading Halt: Halt News Pending

BenzingaDec 14 06:27

FDA Decision On Checkpoint Therapeutics' Cosibelimab Due On Dec.28 - Will Second Time Be The Charm?

RTTNewsDec 12 17:17